Zum Hauptinhalt springen

HIV

26. März 2017 | HIV

TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir.

TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir. Wyles D, Saag M, Viani RM, Lalezari J, Adeyemi O, Bhatti L, Khatri A, King JR, Hu YB, Tri…

25. März 2017 | HIV

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir: Drug Interactions With Antiretroviral Agents and Drugs for Substance Abuse.

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir: Drug Interactions With Antiretroviral Agents and Drugs for Substance Abuse. King JR, Menon RM. Clin Pharmacol Drug Dev. 2017 Mar;6(2):201-205. doi: 10.1002/cpdd.327. http://onlinelibrary.wiley.com/…

22. März 2017 | HIV

UNAIDS: Stopping the rise of new HIV infections among people who inject drugs

As part of UNAIDS’ efforts to stop the rise of new HIV infections among people who inject drugs UNAIDS is taking an urgent message to the Commission on Narcotic Drugs, as it meets in Vienna, Austria, for its sixtieth session. In a statement to…

21. März 2017 | HIV

Providing HIV Treatment To Those Who Are Known To Be Infected Is Not Enough To Prevent Its Spread Among People Who Inject Drugs

People who inject drugs (PWID) are at risk for HIV infection and for transmitting the virus to others. One strategy for reducing transmission is to identify individuals who are HIV-infected and provide antiretroviral treatment (ART) to them (i.e., &…

21. März 2017 | HIV

Providing HIV Treatment To Those Who Are Known To Be Infected Is Not Enough To Prevent Its Spread Among People Who Inject Drugs

People who inject drugs (PWID) are at risk for HIV infection and for transmitting the virus to others. One strategy for reducing transmission is to identify individuals who are HIV-infected and provide antiretroviral treatment (ART) to them (i.e., &…

21. März 2017 | HIV

PrEP In People Who Inject Drugs: Factors Associated with Patient Uptake And Adherence

PrEP In People Who Inject Drugs: Factors Associated with Patient Uptake And Adherence (Alcohol, Other Drugs, and Health: Current Evidence, March-April 2017) http://www.bu.edu/aodhealth/2017/03/16/prep-in-people-who-inject-drugs-factors-associated-…

20. März 2017 | HIV

Joint estimation of CD4 progression and survival in untreated individuals with HIV-1 infection: A pooled analysis of data from 25 countries.

Joint estimation of CD4 progression and survival in untreated individuals with HIV-1 infection: A pooled analysis of data from 25 countries. Mangal TD. AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001437. Abstract https://www.ncbi.nlm.nih.gov/p…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten